It is currently Wed Dec 07, 2016 2:09 pm

News News of Tcelna (Tovaxin)

Site map of Tcelna (Tovaxin) » Forum : Tcelna (Tovaxin)

A board to discuss Tcelna as a treatment for Multiple Sclerosis

tovaxin phase III

Hi,
I am an italian girl, i was diagnosed in 1999.
I would like to know when Tovaxin will end Phase II trial.
Does someone know if this drug will start phase III?
And when? Do you think there will be some centre in Europe starting phase III?
thank you for your reply!!
Read more : tovaxin phase III | Views : 5760 | Replies : 24


Getting the Ball Rolling (aka "Rough Draft")

Get your cyber blue pencils at the ready and have fun! If I don't have to do TOO many re-writes, I (we) might get this out by week's end!

God Bless Us One and All...

My full address
Date
Their full address w/their exciting titles, of course

Dear Dr./Mr./Ms. So-and-So:

My name is Jane ____ (not “the Pain” because this is VERY official, dontcha know?) and I was a patient in the Tovaxin clinical study ...
Read more : Getting the Ball Rolling (aka "Rough Draft") | Views : 3303 | Replies : 13


Termination Appt. and What Did You Switch To

Hey gang,

I thought it would be interesting to have a topic where we post how the termination appointment went as well as what meds/treatment did you decide to switch to. My termination appointment is tomorrow so I will update you then.

Take care,
Mike
Read more : Termination Appt. and What Did You Switch To | Views : 13454 | Replies : 81


Alternative Funding Sources

..
Read more : Alternative Funding Sources | Views : 2312 | Replies : 5


Its over

I just got a call from my coordinator and Opexa is suspending Tovaxin.
Thats all I know at this point.
Will have to research what my next adventure will be.

Its been a wild ride, for sure!
Read more : Its over | Views : 10903 | Replies : 62


Opexa Presentation Nov 11

Opexa to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced that Neil K. Warma, Opexa’s president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw’s 10th Annual Healthcare Conference. The conference will be held November 10-12, 2008, ...
Read more : Opexa Presentation Nov 11 | Views : 5826 | Replies : 25


Off-Topic Reminder!

Okay, Tovaxinites, get out there today and VOTE! I hear that some precincts are providing free coffee and Dunkin'/ Krispy Kremes. Do let me know if you're in one of those districts... I may meander over and join you...

:lol:
Read more : Off-Topic Reminder! | Views : 1929 | Replies : 2


Racing Against the Clock

Disclosure: While Kim is on ABX, I have been vouyeristicly interested in Tovaxin and have been hoping for it’s success. I even invested in the stock, which I still have.

Opexa released a 10-Q today. The 10-Q is a report that public companies are required to submit to the securities and exchange commission. There are often some interesting nuggets of knowledge in these reports and I thought folks here might be interested in what Opexa ...
Read more : Racing Against the Clock | Views : 1650 | Replies : 0


New Data from Opexa

Opexa Provides Additional Promising Data Including Statistically Significant Reduction in Disability With Tovaxin® for the Treatment of Multiple Sclerosis

Tovaxin Also Demonstrates Reduction in Relapse Risk and Myelin T-cell Reactivity in Patients With More Active Disease

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes, today announced additional positive data from the company’s Phase ...
Read more : New Data from Opexa | Views : 2961 | Replies : 7


Av8rgirl's results on Tovaxin - Phase IIb

I started the screening process for the Phase IIb trial in Jan of 2007. I received my first vaccine in March and the last vaccine on 9/21/2007.

In July of 2007, I had a major exacerbation which was treated with 3 days of IVSM.

The trial ended for me on April 1, 2008. Two weeks later, I had another exacerbation which was treated with 3 days of IVSM.

I was dx'd with RRMS in March ...
Read more : Av8rgirl's results on Tovaxin - Phase IIb | Views : 5499 | Replies : 22


 

Login  •  Register


Statistics

Total posts 235152 • Total topics 25376 • Total members 16585


Contact us | Terms of Service